AVORO CAPITAL ADVISORS LLC – Amicus Therapeutics, Inc. Transaction History
AVORO CAPITAL ADVISORS LLC portfolio value:
$279.79M
portfolio value
AVORO CAPITAL ADVISORS LLC quarter portfolio value change:
-2.79%
quarter
Amicus Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -8.04M | $10.44 | 26.8M | |
| Q2 2022 | share | Increase | +30.73% | 6.3M shares | 93.69M | $10.74 | 26.8M |
| Q1 2022 | share | Increase | +10.81% | 2M shares | -19.54M | $9.47 | 20.5M |
| Q4 2021 | share | Increase | +4.64% | 820.72K shares | 44.83M | $11.67 | 18.5M |
| Q3 2021 | share | Increase | +42.00% | 5.22M shares | 48.81M | $9.55 | 17.67M |
| Q2 2021 | share | Increase | +1.63% | 200K shares | -1.01M | $9.64 | 12.45M |
| Q1 2021 | share | Increase | +36.11% | 3.25M shares | -86.78M | $9.88 | 12.25M |
| Q4 2020 | share | Decrease | -17.05% | -1.85M shares | 54.60M | $23.09 | 9M |
| Q3 2020 | share | Decrease | -1.36% | -150K shares | -12.67M | $14.12 | 10.85M |
| Q2 2020 | share | Increase | +0.46% | 50K shares | 64.70M | $15.08 | 11M |
| Q1 2020 | share | Decrease | -2.23% | -250K shares | -7.91M | $9.24 | 10.95M |
| Q4 2019 | share | Increase | +0.90% | 100K shares | 20.06M | $9.74 | 11.2M |
| Q3 2019 | share | Increase | +11.00% | 1.1M shares | -35.77M | $8.02 | 11.1M |
| Q2 2019 | share | Increase | +5.26% | 500K shares | -4.4M | $12.48 | 10M |
| Q1 2019 | share | Increase | 0.00% | 9.5M shares | 129.2M | $13.6 | 9.5M |
| Q4 2018 | share | Increase | +8.48% | 791.86K shares | -15.84M | $9.58 | 10.12M |
| Q3 2018 | share | Decrease | -0.38% | -36.01K shares | -33.50M | $12.09 | 9.33M |
| Q2 2018 | share | Decrease | -1.43% | -136.29K shares | 3.38M | $15.62 | 9.36M |
| Q2 2018 | call | Decrease | -100.00% | -2.35M shares | -3.76M | $15.62 | 0 |
| Q1 2018 | call | Increase | +56.67% | 850.1K shares | 1.99M | $15.04 | 2.35M |
| Q1 2018 | share | Increase | +30.87% | 2.24M shares | 38.44M | $15.04 | 9.50M |
| Q4 2017 | call | Decrease | -50.00% | -1.5M shares | -6.63M | $14.39 | 1.5M |
| Q4 2017 | share | Increase | +12.83% | 826K shares | 7.44M | $14.39 | 7.26M |
| Q3 2017 | call | Increase | +1100.00% | 2.75M shares | 7.86M | $15.08 | 3M |
| Q3 2017 | share | Increase | +8.53% | 506.16K shares | 37.34M | $15.08 | 6.43M |
| Q2 2017 | share | Increase | +22.35% | 1.08M shares | 25.16M | $10.07 | 5.93M |
| Q2 2017 | call | 0.00% | 0 shares | 326K | $10.07 | 250K | |
| Q1 2017 | share | Increase | +20.66% | 830K shares | 14.59M | $7.13 | 4.84M |
| Q1 2017 | call | Increase | 0.00% | 250K shares | 206K | $7.13 | 250K |
| Q4 2016 | share | Increase | +8.88% | 327.72K shares | -7.33M | $4.97 | 4.01M |
| Q3 2016 | share | Decrease | -0.24% | -8.80K shares | 7.11M | $7.4 | 3.68M |
| Q2 2016 | share | Increase | +8.02% | 274.56K shares | -8.73M | $5.46 | 3.69M |
| Q1 2016 | share | Decrease | -2.60% | -91.50K shares | -5.16M | $8.45 | 3.42M |